New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2014
13:24 EDTVMW, ORCL, RHT, TIBXEarnings Preview: Oracle guidance seen at risk by Morgan Stanley
Oracle (ORCL) is expected to report third quarter earnings after the bell on Tuesday, March 18, with a conference call scheduled for 5:00 pm ET. Oracle provides software, hardware and IT services to business customers. EXPECTATIONS: Analysts are looking for earnings per share of 70c on revenue of $9.36B. The consensus range is 68c-71c for EPS and $9.29B-$9.49B for revenue, according to First Call. During its last earnings conference call, Oracle said it expects Q3 adjusted EPS to be between 68c-72c. At that time the company also projected its Q3 revenue to grow 3%-7% in constant currency terms compared to the prior year, or 2%-6% in terms of U.S. dollars. LAST QUARTER: The company reported Q2 adjusted EPS of 69c, topping the consensus expectation of 67c. Oracle's revenue of $9.27B also beat the $9.19B consensus projection. Oracle reported its Q2 hardware systems products revenues fell 3% from the prior year, that its Q2 non-GAAP new software licenses and cloud software subscriptions revenues declined 1% and that its Q2 license updates and product support revenues grew 6%. NEWS: Throughout this quarter, Oracle made several acquisitions. The largest of those was Oracle's agreement to buy Responsys for $27.00 per share in cash, or approximately $1.5B, net of Responsys' cash. Responsys' offerings are used by businesses to manage and orchestrate marketing interactions with their customers across email, mobile, social, display and the web. On February 6, the deal was completed and Responsys was merged into Oracle. On January 7, Oracle announced that it has agreed to acquire Corente, a provider of software defined networking technology for wide area networks. On February 24, Oracle agreed to acquire BlueKai, which owns a platform that centrally organizes a company's customer and audience data in the cloud and also runs a third party data marketplace to augment a company's proprietary customer data. STREET RESEARCH: On January 22, Piper Jaffray raised its price target for Oracle shares to $43 from $36 citing its favorable partner survey and the company's headcount growth. That same day, Oracle was upgraded to Buy from Hold at Deutsche Bank, which raised its price target on the stock to $45 from $33, but the stock was also downgraded to Perform from Outperform at Oppenheimer, which cited a more balanced risk/reward profile given the share levels at that time. In a note issued last Friday, Morgan Stanley said it saw limited upside in either Oracle or another provider of middleware and infrastructure software that also reports this week, TIBCO Software (TIBX). Morgan Stanley contended that while both companies have achievable quarters, the firm sees risk, particularly for TIBCO, for forward guidance to fall short of the consensus view. Morgan added that it continues to favor Red Hat (RHT) and VMware (VMW) in infrastructure software. PRICE ACTION: In afternoon trading, Oracle shares were up nearly 1% to $38.55. Over the last three months, Oracle shares have advanced about 11%.
News For ORCL;TIBX;RHT;VMW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2015
07:17 EDTORCLStrategic News Service to hold a conference
Subscribe for More Information
October 5, 2015
14:33 EDTVMWApple won't renew expiring VMware licensing deal, CRN reports
Apple (AAPL) has been using VMware (VMW) software to run parts of its corporate IT infrastructure, but the iPhone giant won't renew an expiring enterprise licensing agreement with VMware and will be stepping up its deployment of an open-source alternative, according to CRN, citing multiple sources with knowledge of the matter. One source said the VMware ELA extension would have cost around $20M, the report noted. VMware shares are still up fractionally in afternoon trading but have slipped from where they were trading before the CRN report was circulated. Reference Link
14:29 EDTVMWApple won't renew expiring VMware licensing deal, CRN reports
Subscribe for More Information
October 2, 2015
09:36 EDTVMWVMware downgraded to Negative from Mixed at OTR Global
September 30, 2015
06:58 EDTORCLOracle to furlough workers during holiday week, BI reports
Oracle has decided to close down during the holiday week between Christmas and New Year's, mandating that its employees pay for this furlough with paid vacation time, Business Insider reports, citing several sources. Some Oracle employees have been angered about this move that basically removes four days of paid time off from them, the report says. Reference Link
06:12 EDTVMWEMC's Goulden: Breaking off VMware 'wrong thing to do,' Re/code reports
EMC (EMC) president David Goulden said his firm will try to maintain its complex corporate structure amid pressure to spin off its stake in VMware (VMW), Re/code reports. "We believe strongly that breaking up is the wrong thing to do," Goulden said in an interview at Re/code's Code/Enterprise Series event. Reference Link
September 29, 2015
08:39 EDTORCLOracle Health Sciences adds 93 biopharma customers
Oracle (ORCL) Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster. Organizations, including Accera and NewLink (NLNK), selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.
September 28, 2015
10:14 EDTRHTOptions with decreasing implied volatility
Options with decreasing implied volatility: HRTX ARWR RHT BBBY
September 25, 2015
10:53 EDTRHTOptions with decreasing implied volatility
Subscribe for More Information
September 24, 2015
10:25 EDTRHTOptions with decreasing implied volatility
Options with decreasing implied volatility: HRTX ATML ARRY YY OVTI RHT KMX
September 23, 2015
10:26 EDTVMWEMC standstill agreement with activist expired on Sept. 1, Re/code reports
The standstill agreement between EMC (EMC) and activist investor Elliott Management expired on September 1, Arik Hesseldahl of Re/code reports, citing people familiar with the terms. EMC may have asked Elliott for an informal extension of the agreement as its board weighs its options since Elliott has yet to resume its public campaign of pushing for a breakup, Hesseldahl adds. Reference Link
10:20 EDTRHT, ORCLOptions with decreasing implied volatility
Options with decreasing implied volatility: CVC HRTX NWBO ATML RHT KMX OVTI ADBE ORCL DRI
September 22, 2015
12:14 EDTRHTOn The Fly: Top stock stories at midday
Stocks began the session deep in negative territory and have remained there throughout the morning. There has been little in the way of buying as the downward pressure in the market has not shown any sign of letting up. There is also little in the way of explanation as to why the market is so weak other than continued disappointment in the Fed's interest rate decision and the ongoing concern over China's economic growth. ECONOMIC EVENTS: In the U.S., the FHFA home price index rose 0.6% to 224.5 in July, which was better than the 0.4% rise that was expected. The Richmond Fed factory index fell to -5 in September, versus the reading of 2 that was expected. COMPANY NEWS: Shares of Groupon (GRPN) slumped 2.5% after the online and mobile deal provider said it plans to cut more than 1,000 jobs relating primarily to the company's international operations. The news is the latest in a recent run of job cut announcements, after HP Enterprise said last week that it expects 25,000-30,000 people to leave the company and Johnson Controls (JCI) recently announced plans to reduce its global salaried workforce by as many as 3,000 people... Lloyd Blankfein, Goldman Sachs (GS) chairman and CEO, disclosed that he was told by doctors that he has lymphoma. "Fortunately, my form of lymphoma is highly curable and my doctors' and my own expectation is that I will be cured," Blankfein stated in an open letter that was shared by the bank. MAJOR MOVERS: Among the notable gainers was Weatherford (WFT), which rose 9.6% after stating that it has decided not to pursue its previously announced concurrent public offerings of ordinary shares of the company and mandatorily exchangeable subordinated notes. Also higher was Vascular Biogenics (VBLT), which gained 15% to around $9.30 per share after the stock was initiated with a Buy rating and $25 price target at Chardan. Among the noteworthy losers following their earnings reports were ConAgra (CAG) and Carnival (CCL), which each fell more than 5%, and Red Hat (RHT), which slid 2%. Also lower were shares of Staples (SPLS) and Office Depot (ODP), which fell 7% and 8%, respectively, after the New York Post said a top FTC regulator may be leaning toward recommending against approving their merger agreement. INDEXES: Near midday, the Dow was down 263.77, or 1.6%, to 16,246.42, the Nasdaq was down 99.52, or 2.06%, to 4,729.44, and the S&P 500 was down 32.51, or 1.65%, to 1,934.46.
10:14 EDTRHTOptions with decreasing implied volatility
Options with decreasing implied volatility: CVC ADXS SRPT ATML YY SCTY OLN ADBE RHT ASNA
08:08 EDTVMWVMware expands relationship with SAP
VMware (VMW) announced the expansion of its relationship with SAP (SAP). SAP and VMware plan to integrate the ACE approach to enable secure, instant deployment and login of SuccessFactors and Concur mobile applications on iOS and Android devices. The ACE community also announced today 21 new members, growing more than seven-fold since its inception in March 2015.
08:08 EDTVMWVMware extends Samsung partnership to include AirWatch
Subscribe for More Information
07:46 EDTRHTRed Hat remains among best positioned infra-software companies, says UBS
UBS said Red Hat remains one of the best positioned pure-play infra-software companies following its steady Q2 results. The firm said the only blemish on the quarter is its as-reported billings, which the firm notes may bounce around from quarter-to-quarter. UBS is incrementally more positive on Red Hat following its recent pullback and reiterated its Buy rating while lowering its price target on shares to $85 from $88.
07:20 EDTRHTRed Hat billings can accelerate in 2H15, says RBC Capital
Subscribe for More Information
06:26 EDTRHTRed Hat price target raised to $89 from $85 at JPMorgan
Subscribe for More Information
06:05 EDTRHTRed Hat Q2 results better than they appear, says Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use